SciELO - Scientific Electronic Library Online

 
vol.14 número3Dislipidemia mixta severa en población pediátrica: enfoque diagnóstico y terapéutico. A propósito de un caso índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista Venezolana de Endocrinología y Metabolismo

versão impressa ISSN 1690-3110

Resumo

HUNG, Seilee et al. Morquio Syndrome as a rare cause of disproportionate short stature: Pathophysiological, diagnostic and therapeutic approach. About a case. Rev. Venez. Endocrinol. Metab. [online]. 2016, vol.14, n.3, pp.217-225. ISSN 1690-3110.

Objective: To describe a case of Morquio syndrome as a rare cause of disproportionate short stature. Case report: Female 11 years old who initiates current disease at 4 years of age with growth retardation, short stature, deformity of the chest and extremities. Three times was hospitalized for respiratory infections She also has persistent nasal obstruction, recurrent tonsillitis, night snoring and hearing loss in the right ear. Physical examination: Weight: 19.8 kg (P <3) Height: 97cm (P <3), BMI: 21.5 (P 90), relation proximal/distal segment: 0.87, growth rate of 0 cm/year. Normocephalic, eyes with hypertelorism and bilateral epicanto, broad nasal bridge, keeled chest, scoliosis, and rosary costal. Limbs: epiphyseal thickening, 5th bilateral short metacarpal. Calyx deformity in hands and feet, genus valgus and bilateral flatfoot. Paraclinical: Alkaline phosphatase: 768 mg/ dL, calcium: 10 mg/dL, phosphorus 4.1 mg/dL, TSH 2.2 mU/mL, FT4 1.1 ng/dL, PTH: 31.8 ng/dL, remaining unchanged. Bone age of 10 years. Genetic evaluation: Morquio Syndrome. Conclusion: Morquio syndrome is an uncommon cause of disharmonic short stature, and it is a challenge in the diagnosis and treatment. The growth hormone therapy is not recommended routinely because of the few studies on safety and efficacy, partly due to the low prevalence of this disease, so it is a future goal for the improvement of short stature in these patients.

Palavras-chave : Morquio syndrome; mucopolysaccharidosis; short stature; glycosaminoglycans.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )